Actual Medicinal Product (AMP) Maxalt 10mg tablets (Mawdsley-Brooks & Company Ltd)

Stability Information

(Some stability information inherited from generic)

Stability

Suitable for use in MCAs, although use is likely to be off-label. Keep medicines in MCAs for the shortest time necessary. Generally, up to 5 weeks maximum unless otherwise specified, or up to 8 weeks if the MCA is airtight (sealed). Consider the risk of potency loss or dose variability and monitor for changes in efficacy or adverse effects after MCA initiation.

Notes

No special requirements for storage.

Provenance

This compatibility recommendation is derived from Maxalt 10mg tablets (Organon Pharma (UK) Ltd).

Generic

Rizatriptan

Formulation

Rizatriptan 10mg tablets

Alternative Suppliers (21)

Maxalt 10mg tablets (Organon Pharma (UK) Ltd)

Maxalt 10mg tablets (Sigma Pharmaceuticals Plc)

Maxalt 10mg tablets (Lexon (UK) Ltd)

Rizatriptan 10mg tablets (Aspire Pharma Ltd)

Rizatriptan 10mg tablets (A A H Pharmaceuticals Ltd)

Rizatriptan 10mg tablets (Alliance Healthcare (Distribution) Ltd)

Rizatriptan 10mg tablets (Accord Healthcare Ltd)

Rizatriptan 10mg tablets (DE Pharmaceuticals)

Rizatriptan 10mg tablets (Milpharm Ltd)

Rizatriptan 10mg tablets (Tillomed Laboratories Ltd)

Maxalt 10mg tablets (CST Pharma Ltd)

Rizatriptan 10mg tablets (Medihealth (Northern) Ltd)

Rizatriptan 10mg tablets (Glenmark Pharmaceuticals Europe Ltd)

Rizatriptan 10mg tablets (Necessity Supplies Ltd)

Maxalt 10mg tablets (Dowelhurst Ltd)

Maxalt 10mg tablets (Waymade Healthcare Plc)

Maxalt 10mg tablets (Mawdsley-Brooks & Company Ltd)

Maxalt 10mg tablets (DE Pharmaceuticals)

Rizatriptan 10mg tablets (Accord-UK Ltd)

Rizatriptan 10mg tablets (Lupin Healthcare (UK) Ltd)

Rizatriptan 10mg tablets (Mawdsley-Brooks & Company Ltd)

Related Formulations (5)

Rizatriptan 5mg tablets

Rizatriptan 10mg tablets

Rizatriptan 10mg oral lyophilisates sugar free

Rizatriptan 10mg orodispersible tablets sugar free

Rizatriptan 5mg orodispersible tablets sugar free